CCI gives nod to Mylan-Unichem acquisition Illustrative image – not actual.

The Competition Commission of India (CCI) has sactioned acquisition of Mylan Laboratories and Unichem Laboratories.


CCI has given its nod, as, Mylan Laboratories, acquiring a manufacturing facility owned by Unichem Laboratories, will not have an adverse effect on competition. The manufacturing facility located in Dhar district of Madhya Pradesh produces 'Finished Dosage Forms (FDFs)'.


Mylan, through this acquisition, intends to export products to be manufactured at the said facility.


Mylan has 11 manufacturing facilities across India, of which eight are for the manufacture of Active Pharmaceutical Ingredients (API) and two are for making FDFs.


Unichem has seven manufacturing facilities in India, of which two facilities are for the manufacture of APIs and five are for FDFs.

 


 

← All latest storiesBack to top →